Symbios
Vitória, Espírito Santo, BrazilSee on the map
- Neurorehabilitation and assistive tech
Symbios develops m-FLEX, a portable robotic platform for upper-limb neuromotor rehabilitation. Designed for use across clinics, hospital wards, and homes, it combines assisted movement, interactive therapeutic activities, and session-level progress tracking.
- RaisedTotal raised
- $25.2M
- Investors
- 5
reccy insights
Symbios has advanced its footprint in the digital health and medical device sector through the continuous development and deployment of its flagship m-FLEX platform. Designed to facilitate portable upper-limb neuromotor rehabilitation, the technology bridges clinical and home care environments. In October 2025, the company secured a Venture Capital financing round backed by Hopewell Ventures, pointing to continued interest in scalable, software-integrated robotic hardware for rehabilitation. Over the years, the company has bolstered its financial backing through multiple funding milestones, including grants and debt financing from institutional entities such as the National Science Foundation, National Cancer Institute, and the Department of Energy.
Written by reccy's AI from company sites, press and funding records · updated Nov 2026
What makes Symbios distinct
- 01Portable design lets therapists bring robotic rehabilitation beyond specialized clinical centers, without installation or a dedicated room.
- 02Supports elbow flexion and extension, forearm pronation and supination, and hand opening and closing in one system.
- 03Records repetitions, movement speed, robotic assistance, and patient progression to support objective monitoring across sessions.
- 04Integrates therapeutic activities and games to make rehabilitation sessions interactive.
- 05Designed to expand access to advanced rehabilitation across clinical, educational, research, and home settings.
Technology & products
- m-FLEX
A portable robotic platform for upper-limb neuromotor rehabilitation designed for clinics, hospital wards, and home use.
- m-FLEX portable robotic rehabilitation platform
- Robotic assistance for upper-limb movement across the elbow, forearm, and hand
- Session tracking for repetitions, movement speed, assistance level, and patient progression
- Therapeutic activities and games integrated into rehabilitation sessions
Research roots1
Labs and research groups this company came from or works with.
Funding
- Venture CapitalOct 2025Hopewell Ventures
- DebtJan 2021$44KLed by PPP
- GrantJan 2017$8.4MLed by DOE
Investors7
- National Cancer Institute
- DOE
- Hopewell Ventures
- U.S. Small Business Administration
- local investors
Similar companies
About Symbios
- Products
- m-FLEX
- Focus areas
- Healthcare, medical devices, digital health, rehabilitation, robotics, neuromotor rehabilitation, assistive technology, remote care
- Headquarters
- Vitória, Espírito Santo, Brazil